Based on clinical record review and interview, it was determined that for two (R31 and R53) out of five residents reviewed for unnecessary medications, the physician failed to ensure that an appropriate diagnosis was reflected in the resident's chart while antipsychotic medications were being administered. Additionally, the facility failed to ensure that a fourteen day stop date was implemented for an as needed antipsychotic medication. Findings include: 1. Review of R31's clinical record included: 2/13/19 - R31 was admitted to the facility with the following diagnosis, but not limited to, psychotic disorder with delusions. 1/24/25 - A physician's order for R31 documented risperidone (antipsychotic) tablet 0.5 mg: give one tablet by mouth at bedtime for delusional disorder. …
F758 citations in Delaware
Psychotropic drugs · Pharmacy Service Deficiencies
Implement gradual dose reductions(GDR) and non-pharmacological interventions, unless contraindicated, prior to initiating or instead of continuing psychotropic medication; and PRN orders for psychotropic medications are only used when the medication is necessary and PRN use is limited.
Data as of , released by CMS on October 8, 2026. Source: CMS Provider Data Catalog.
Against expectation — 2025
Delaware cites F758 more often than its own record predicts
1.35 times the share F758 takes of citations nationally.
Of every deficiency written in Delaware in 2025, this is the portion that was F758.
Each state is measured against its own expected share, not against other states.
In the surveyor’s words
What Delaware surveyors wrote
F758 findings written in Delaware, one from each severity band recorded here, most serious first.
Severity is as the surveyor wrote it. Some findings had already been corrected before the survey.
The short window
Recent years
| Year | Share of Delaware citations | vs expected |
|---|---|---|
| 2023 | 2.38% | 1.44× |
| 2024 | 1.58% | 1.06× |
| 2025 | 0.85% | 1.35× |
Shares of citations, not counts: earlier years hold fewer inspections.
What else Delaware surveyors cite →
Deficiency Index is independent and is not affiliated with, endorsed by, or approved by CMS, Medicare, or any government agency. About this data · Report a correction